Lucid Capital analyst Alex Fuhrman initiated coverage of Enhanced Group (ENHA) with a Buy rating and $15 price target The firm says demand for longevity treatments has been rising and that Enhanced has a plan to bring “exclusive concierge-level care into the mainstream.” The company is well positioned to capitalize on longevity demand with its scalable direct-to-consumer platform, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds